.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Merck
Cerilliant
Julphar
Argus Health
Cipla
Daiichi Sankyo
US Department of Justice
Moodys

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019879

« Back to Dashboard

NDA 019879 describes ORNIDYL, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the ORNIDYL profile page.

The generic ingredient in ORNIDYL is eflornithine hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.

Summary for 019879

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 019879

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength200MG/ML
Approval Date:Nov 28, 1990TE:RLD:No

Expired Orange Book Patents for NDA: 019879

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsORNIDYLeflornithine hydrochlorideINJECTABLE;INJECTION019879-002Nov 28, 1990► Subscribe► Subscribe
Sanofi Aventis UsORNIDYLeflornithine hydrochlorideINJECTABLE;INJECTION019879-002Nov 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Dow
Chubb
Cerilliant
Merck
Covington
Daiichi Sankyo
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot